Eugene Gerner, PhD | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
researchers

Eugene Gerner, PhD

Researcher
Director
Gastrointestinal Cancer Program
Arizona Cancer Center
Tucson, Arizona, United States

CEO, Cancer Prevention Pharmaceuticals (CPP)

Cancer Prevention Pharmaceuticals (CPP) is a company in the late stages of developing drugs and drug combinations to treat people with risk factors for cancer. Some of these people have genetic risk factors, such as defects in the adenomatous poly posits coli tumor suppressor gene which cause the familial adenomatous polyposis (FAP) syndrome. Others have sporadic risk factors, such as prior colorectal cancer or neuroblastoma with amplified copies of the MYCN oncogene. CPP is also developing companion diagnostics for its drug therapies.

view online profile

expertly curated content related to this topic